Alternative splicing, epigenetic modifications and cancer: a dangerous triangle, or a hopeful one?

F Gimeno-Valiente, G López-Rodas, J Castillo… - Cancers, 2022 - mdpi.com
Simple Summary Epigenetics studies the alteration of gene expression without changing
DNA sequence and very often, epigenetic dysregulation causes cancer. Alternative splicing …

Splicing dysregulation in human hematologic malignancies: beyond splicing mutations

J De Kesel, I Fijalkowski, J Taylor, P Ntziachristos - Trends in immunology, 2022 - cell.com
Splicing is a fundamental process in pre-mRNA maturation. Whereas alternative splicing
(AS) enriches the diversity of the proteome, its aberrant regulation can drive oncogenesis …

Single-cell transcriptomics reveals the expression of aging-and senescence-associated genes in distinct cancer cell populations

D Saul, RL Kosinsky - Cells, 2021 - mdpi.com
The human aging process is associated with molecular changes and cellular degeneration,
resulting in a significant increase in cancer incidence with age. Despite their potential …

Aberrantly reduced expression of miR-342-5p contributes to CCND1-associated chronic myeloid leukemia progression and imatinib resistance

YY Wu, HF Lai, TC Huang, YG Chen, RH Ye… - Cell Death & …, 2021 - nature.com
Chronic myeloid leukemia (CML) is a myeloproliferative disorder associated with the
Philadelphia chromosome, and the current standard of care is the use of tyrosine kinase …

DNA methylation and intra-clonal heterogeneity: The chronic myeloid leukemia model

B Lebecque, C Bourgne, V Vidal, MG Berger - Cancers, 2021 - mdpi.com
Simple Summary In Chronic Myeloid Leukemia (CML), intra-clonal heterogeneity is a major
factor in the response to tyrosine kinase inhibitors and in leukemia stem cell persistence …

EZH2 modulates mRNA splicing and exerts part of its oncogenic function through repression of splicing factors in CML

R Brunmeir, L Ying, J Yan, YT Hee, B Lin, H Kaur… - Leukemia, 2025 - nature.com
The polycomb protein EZH2 is up-regulated in Chronic Myeloid Leukaemia (CML) and
associated with transcriptional reprogramming. Here we tested whether EZH2 might also act …

The Fusion of CLEC12A and MIR223HG Arises from a trans-Splicing Event in Normal and Transformed Human Cells

BP Dhungel, G Monteuuis, C Giardina… - International journal of …, 2021 - mdpi.com
Chimeric RNAs are often associated with chromosomal rearrangements in cancer. In
addition, they are also widely detected in normal tissues, contributing to transcriptomic …

Properties of leukemic stem cells in regulating drug resistance in acute and chronic myeloid leukemias

X Zhai, X Jiang - Biomedicines, 2022 - mdpi.com
Notoriously known for their capacity to reconstitute hematological malignancies in vivo,
leukemic stem cells (LSCs) represent key drivers of therapeutic resistance and disease …

Towards resolution of the intron retention paradox in breast cancer

JS Shah, MJG Milevskiy, V Petrova, AYM Au… - Breast Cancer …, 2022 - Springer
Background After many years of neglect in the field of alternative splicing, the importance of
intron retention (IR) in cancer has come into focus following landmark discoveries of …

Lentiviral-driven discovery of cancer drug resistance mutations

P Yenerall, RK Kollipara, K Avila, M Peyton, CA Eide… - Cancer research, 2021 - AACR
Identifying resistance mutations in a drug target provides crucial information. Lentiviral
transduction creates multiple types of mutations due to the error-prone nature of the HIV-1 …